| Primary |
| Constipation |
66.7% |
| Pancreatic Carcinoma |
33.3% |
|
|
| Secondary |
| Product Used For Unknown Indication |
34.6% |
| Constipation |
9.7% |
| Drug Use For Unknown Indication |
8.2% |
| Supplementation Therapy |
7.1% |
| Pain |
5.8% |
| Hypertension |
5.1% |
| Pancreatitis |
4.1% |
| Prophylaxis |
3.6% |
| Sedation |
3.1% |
| Analgesic Therapy |
2.8% |
| Hiv Infection |
2.8% |
| Glaucoma |
2.6% |
| Thrombosis Prophylaxis |
2.4% |
| Nausea |
1.3% |
| Withdrawal Syndrome |
1.3% |
| Infection |
1.2% |
| Alcohol Withdrawal Syndrome |
1.1% |
| Atrial Fibrillation |
1.1% |
| Fatigue |
1.1% |
| Fluid Replacement |
1.1% |
|
| Toxic Epidermal Necrolysis |
12.3% |
| Renal Failure |
8.6% |
| Tumour Haemorrhage |
8.6% |
| Hypertriglyceridaemia |
7.4% |
| Nephropathy Toxic |
7.4% |
| Weight Increased |
7.4% |
| Oedema Peripheral |
4.9% |
| Persecutory Delusion |
4.9% |
| Death |
3.7% |
| Hepatitis Cholestatic |
3.7% |
| Hypotonia |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Syncope |
3.7% |
| Tendonitis |
3.7% |
| Tubulointerstitial Nephritis |
3.7% |
| Drug Exposure During Pregnancy |
2.5% |
| Extrapyramidal Disorder |
2.5% |
| Hyponatraemia |
2.5% |
| Irritable Bowel Syndrome |
2.5% |
| Pain |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.8% |
| Drug Use For Unknown Indication |
14.5% |
| Constipation |
10.5% |
| Pain |
9.4% |
| Hypertension |
6.7% |
| Prophylaxis |
6.2% |
| Non-small Cell Lung Cancer |
3.8% |
| Nausea |
3.0% |
| Depression |
2.7% |
| Rhabdomyosarcoma |
1.9% |
| Infection |
1.9% |
| Schizophrenia |
1.9% |
| Prostate Cancer |
1.7% |
| Sarcoma |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.6% |
| Parkinson's Disease |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Metastatic Renal Cell Carcinoma |
1.4% |
| Atrial Fibrillation |
1.3% |
| Diffuse Large B-cell Lymphoma |
1.3% |
|
| Vomiting |
15.5% |
| Somnolence |
9.5% |
| Weight Decreased |
6.7% |
| Urinary Tract Infection |
6.3% |
| Sepsis |
5.4% |
| Thrombocytopenia |
5.4% |
| Pneumonia |
5.0% |
| Syncope |
4.6% |
| Pyrexia |
4.2% |
| Rhabdomyolysis |
4.2% |
| Urinary Retention |
4.2% |
| Renal Impairment |
3.8% |
| Hyponatraemia |
3.6% |
| Pulmonary Embolism |
3.6% |
| Convulsion |
3.0% |
| Death |
3.0% |
| Pain |
3.0% |
| Peritoneal Haemorrhage |
3.0% |
| Gastrointestinal Haemorrhage |
2.8% |
| Renal Failure |
2.8% |
|
| Interacting |
| Convulsion |
57.1% |
| Aspergillosis |
28.6% |
| Product Used For Unknown Indication |
14.3% |
|
| Epilepsy |
66.7% |
| Drug Level Below Therapeutic |
33.3% |
|
